RxDoctor Payments Data

Ronald Renard, MD

Allergy & Immunology · Redding, CANPI 1497792436

Payments from drug & device makers

$274in general payments, 2019–2025

Across 15 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$67
  • GSK$49
  • Sanofi$35
  • Shire North American Group Inc$34
  • AstraZeneca$23
  • CSL Behring$18
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$25693%
  • Education$187%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$274 in reported general payments places this provider in the 20th percentile of 426 allergy & immunology providers in California.

See all allergy & immunology providers in California

Medicare billing

Part B allowed, 2024
$1,601
Medicare patients
21
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl13$159

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Redding

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →